London-based genomic data startup Lifebit Biotech has secured $60m in Series B funding from Tiger Global Management, with participation from Eurazeo, Pentech Ventures, and Beacon Capital. Lifebit aims to further its global expansion.
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.